JP2012505928A5 - - Google Patents

Download PDF

Info

Publication number
JP2012505928A5
JP2012505928A5 JP2011533097A JP2011533097A JP2012505928A5 JP 2012505928 A5 JP2012505928 A5 JP 2012505928A5 JP 2011533097 A JP2011533097 A JP 2011533097A JP 2011533097 A JP2011533097 A JP 2011533097A JP 2012505928 A5 JP2012505928 A5 JP 2012505928A5
Authority
JP
Japan
Prior art keywords
composition
composition according
general formula
formula
ocular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011533097A
Other languages
English (en)
Japanese (ja)
Other versions
JP5611216B2 (ja
JP2012505928A (ja
Filing date
Publication date
Priority claimed from KR1020080102660A external-priority patent/KR101116868B1/ko
Application filed filed Critical
Publication of JP2012505928A publication Critical patent/JP2012505928A/ja
Publication of JP2012505928A5 publication Critical patent/JP2012505928A5/ja
Application granted granted Critical
Publication of JP5611216B2 publication Critical patent/JP5611216B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011533097A 2008-10-20 2009-10-16 眼疾患の予防又は治療用組成物 Active JP5611216B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2008-0102660 2008-10-20
KR1020080102660A KR101116868B1 (ko) 2008-10-20 2008-10-20 안질환의 예방 또는 치료용 조성물
PCT/KR2009/005983 WO2010047500A2 (ko) 2008-10-20 2009-10-16 안질환의 예방 또는 치료용 조성물

Publications (3)

Publication Number Publication Date
JP2012505928A JP2012505928A (ja) 2012-03-08
JP2012505928A5 true JP2012505928A5 (https=) 2012-12-06
JP5611216B2 JP5611216B2 (ja) 2014-10-22

Family

ID=42119814

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011533097A Active JP5611216B2 (ja) 2008-10-20 2009-10-16 眼疾患の予防又は治療用組成物

Country Status (7)

Country Link
US (1) US8524686B2 (https=)
EP (1) EP2361627B1 (https=)
JP (1) JP5611216B2 (https=)
KR (1) KR101116868B1 (https=)
DK (1) DK2361627T3 (https=)
ES (1) ES2472440T3 (https=)
WO (1) WO2010047500A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101438744B1 (ko) * 2012-08-02 2014-09-15 전남대학교산학협력단 아디포넥틴을 유효성분으로 포함하는 안구건조증 또는 염증성 안구표면 질환의 예방 또는 치료용 조성물
JP6284341B2 (ja) 2012-10-24 2018-02-28 国立大学法人東京農工大学 未熟児網膜症の治療又は予防剤、未熟児網膜症の検査方法及び未熟児網膜症の治療又は予防物質のスクリーニング方法
WO2018171850A1 (en) * 2017-03-23 2018-09-27 Københavns Universitet Prebiotic compounds or compositions for use in treatment of sjögren's syndrome
KR102495473B1 (ko) 2020-10-06 2023-02-06 서울대학교병원 앰피레귤린을 유효성분으로 포함하는 안질환 치료용 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260280A (en) * 1989-02-07 1993-11-09 Snow Brand Milk Products Co., Ltd. Bacterial toxin neutralizer
EP0546728A3 (en) 1991-12-13 1993-09-08 Alcon Laboratories Inc Physiological tear compositions and methods for their preparation
IT1271624B (it) * 1994-03-21 1997-06-04 Lifegroup Spa Derivati glucosidici di n-acil alchilamine capaci di esercitare effetto o neuroprotettivo utilizzabili nelle patologie acute e croniche del sistema nervoso centrale correlate ad eccitotossicita'
JP4082746B2 (ja) * 1995-03-20 2008-04-30 雪印乳業株式会社 シアリルラクトースの分離方法
US5736533A (en) * 1995-06-07 1998-04-07 Neose Technologies, Inc. Bacterial inhibition with an oligosaccharide compound
JPH0967270A (ja) * 1995-08-31 1997-03-11 Res Dev Corp Of Japan 水晶体混濁の予防および治療法、並びにそのための薬 剤
AU7277798A (en) * 1997-05-01 1998-11-24 Cytel Corporation Use of sialyl galactosides and related compounds as anti-angiogenic agents
US6239088B1 (en) * 1999-03-19 2001-05-29 Color Access, Inc. Nonirritating cleansing composition
SE9904289D0 (sv) * 1999-11-26 1999-11-26 Niklas Arnberg Method and camposition for the treatment of adenovairal ocular infections
US20070286896A1 (en) * 2003-08-01 2007-12-13 National Institute Of Advanced Industrial Science And Technology Therapeutic or Diagnostic Drug for Inflammatory Disease Comprising Targeting Liposome
EP1689348B1 (en) * 2003-12-05 2013-05-15 Children's Hospital Medical Center Oligosaccharide compositions and use thereof in the treatment of infection
WO2007047489A2 (en) * 2005-10-18 2007-04-26 Acadia Pharmaceuticals Inc. Compositions and methods for use in cancer therapy

Similar Documents

Publication Publication Date Title
RU2761436C1 (ru) Композиции и способы лечения нарушений со стороны органа зрения
JP6779614B2 (ja) 水性点眼液
RU2018128980A (ru) Офтальмологические составы для доставки лекарственных средств к заднему сегменту глаза
RU2016133980A (ru) Композиции и способы для лечения заболеваний глаз
RU2632107C2 (ru) Пероральная фармацевтическая композиция для профилактики или лечения синдрома "сухого глаза", содержащая ребамипид или его предшественник
JP2020138980A (ja) ジクアホソルおよびカチオン性ポリマーを含有する眼科用組成物
CN107735091B (zh) 包含伊马替尼作为活性成分的用于预防和治疗干眼病的药物组合物
JP2014533274A5 (https=)
JP2012505928A5 (https=)
JP2021075534A (ja) 水性点眼液
AU2023201678A1 (en) Methods for the use of 5'-adenosine diphosphate ribose (ADPR)
AU2018369853B2 (en) Compounds, compositions and methods for treatment of eye disorders and skin diseases
CN106488907A (zh) O‑烷基‑苯亚甲基胍衍生物及其治疗与错误折叠蛋白质累积有关疾病的治疗用途
CA3147107A1 (en) Compositions and methods for treatment of presbyopia
Bagnis et al. Antiglaucoma drugs: The role of preservative-free formulations
FI3720428T3 (fi) Dobesiliinihappoa käsittävä oftalminen paikalliskoostumus silmän takasegmentin sairauksien hoitoon
RU2019118904A (ru) Распределение в глазу и фармакокинетика композиций лифитеграста
US20250161340A1 (en) Composition for preventing, alleviating or treating dry eye syndrome or meibomian gland dysfunction
US20070203190A1 (en) Hydroxylamines and derivatives for the inhibition of complement activation
JPWO2006098292A1 (ja) 眼疾患治療剤
JP2021517139A5 (https=)
Gazepov et al. Unwanted side effects of travoprost
CN104981243A (zh) 含有四氢吡喃基氨基环戊基羰基四氢吡啶并吡啶衍生物作为有效成分的眼后段疾病的预防或治疗剂
MX2008008016A (en) Topical mecamylamine formulations for ocular administration and uses therof
AU2007221271A1 (en) Hydroxylamines and derivatives for the inhibition of complement activation